Hypercholesterolaemia aggravated and Relapsing fever

Summary:

Relapsing fever is found among people with Hypercholesterolaemia aggravated, especially for people who are female, 30-39 old.

The study analyzes which people have Relapsing fever with Hypercholesterolaemia aggravated. It is created by eHealthMe based on reports of 9 people who have Hypercholesterolaemia aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 20, 2022

9 people who have Hypercholesterolaemia Aggravated and Relapsing Fever are studied.


What is Hypercholesterolaemia aggravated?

Hypercholesterolaemia aggravated (high levels of cholesterol in the blood) is found to be associated with 719 drugs and 310 conditions by eHealthMe.

What is Relapsing fever?

Relapsing fever (bacterial infection characterized by recurring episodes of fever, headache, muscle and joint aches, and nausea) is found to be associated with 210 drugs and 205 conditions by eHealthMe.

Number of Relapsing fever in Hypercholesterolaemia aggravated reports submitted per year:

Would you have Relapsing fever when you have Hypercholesterolaemia aggravated?

Gender of people who have Hypercholesterolaemia Aggravated and experienced Relapsing Fever *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Hypercholesterolaemia Aggravated and experienced Relapsing Fever *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 77.78 %
  • 40-49: 22.22 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Osteoporosis (bones weak and more likely to break): 7 people, 77.78%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 22.22%
  3. Psoriasis (immune-mediated disease that affects the skin): 2 people, 22.22%
  4. Diabetes: 2 people, 22.22%

Common drugs taken by these people *:

  1. Fosamax: 7 people, 77.78%
  2. Remicade: 2 people, 22.22%
  3. Metformin: 2 people, 22.22%
  4. Lantus: 2 people, 22.22%
  5. Humalog: 2 people, 22.22%

Common symptoms for these people *:

  1. Insomnia (sleeplessness): 7 people, 77.78%
  2. Echocardiogram Abnormal: 7 people, 77.78%
  3. Memory Loss: 7 people, 77.78%
  4. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 7 people, 77.78%
  5. Loss Of Consciousness: 7 people, 77.78%
  6. Jaw Disorder (jaw disease): 7 people, 77.78%
  7. Infection: 7 people, 77.78%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 77.78%
  9. High Blood Pressure: 7 people, 77.78%
  10. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 7 people, 77.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Relapsing fever?

Check whether Relapsing fever is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Relapsing fever:

All the drugs that are associated with Relapsing fever:

All the conditions that are associated with Relapsing fever:

How the study uses the data?

The study is based on Relapsing fever and Hypercholesterolaemia aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: